Syndecan 1 (SDC1) Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-Syndecan 1 (SDC1) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | Syndecan 1 (SDC1) |
| Clone | monoclonal |
| Host Species | Rabbit |
| Reactive Species | human |
| Isotype | IgG |
| Format | unconjugated |
| Size | 0.02 mL, 0.05 mL, 0.1 mL |
| Concentration | n/a |
| Applications | Western Blot (WB), Flow Cytometry (FC/FACS) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | The protein encoded by this gene is a transmembrane (type I) heparan sulfate proteoglycan and is a member of the syndecan proteoglycan family. The syndecans mediate cell binding, cell signaling, and cytoskeletal organization and syndecan receptors are required for internalization of the HIV-1 tat protein. The syndecan-1 protein functions as an integral membrane protein and participates in cell proliferation, cell migration and cell-matrix interactions via its receptor for extracellular matrix proteins. Altered syndecan-1 expression has been detected in several different tumor types. While several transcript variants may exist for this gene, the full-length natures of only two have been described to date. These two represent the major varian |
| Immunogen | Source Note: This monoclonal antibody is produced by immunizing animals with a polypeptide corresponding to Syndecan 1 (SDC1) protein. |
| Other Names | [Syndecan-1], [SDC1; CD138; SDC; SYND1] |
| Gene, Accession # | [SDC1], Gene ID: 6382, NCBI: NP_001006947.1, UniProt: P18827 |
| Catalog # | MBS435218 |
| Price | $225, $350, $565 |
| Order / More Info | Syndecan 1 (SDC1) Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies